Institute for Medical Microbiology and Infection Control, University Hospital, Goethe University, Paul-Ehrlich-Str. 40, D-60596 Frankfurt am Main, Germany.
Department of Virology and Rickettsiology, Bundeswehr Institute of Microbiology, Neuherbergstrasse 11, D-80937 Munich, Germany.
FEMS Microbiol Rev. 2022 Jul 20;46(4). doi: 10.1093/femsre/fuac013.
Many of the human infectious pathogens-especially the zoonotic or vector-borne bacteria-are fastidious organisms that are difficult to cultivate because of their strong adaption to the infected host culminating in their near-complete physiological dependence on this environment. These bacterial species exhibit reduced multiplication rates once they are removed from their optimal ecological niche. This fact complicates the laboratory diagnosis of the disease and hinders the detection and further characterization of the underlying organisms, e.g. at the level of their resistance to antibiotics due to their slow growth. Here, we describe the current state of microbiological diagnostics for five genera of human pathogens with a fastidious laboratory lifestyle. For Anaplasma spp., Bartonella spp., Coxiella burnetii, Orientia spp. and Rickettsia spp., we will summarize the existing diagnostic protocols, the specific limitations for implementation of novel diagnostic approaches and the need for further optimization or expansion of the diagnostic armamentarium. We will reflect upon the diagnostic opportunities provided by new technologies including mass spectrometry and next-generation nucleic acid sequencing. Finally, we will review the (im)possibilities of rapidly developing new in vitro diagnostic tools for diseases of which the causative agents are fastidiously growing and therefore hard to detect.
许多人类传染病原体——特别是人畜共患病原体或媒介传播的细菌——是难以培养的苛刻生物体,因为它们强烈适应受感染的宿主,最终几乎完全依赖于这种环境才能生存。这些细菌一旦脱离其最佳生态位,繁殖速度就会降低。这一事实使疾病的实验室诊断变得复杂,并阻碍了对潜在病原体的检测和进一步鉴定,例如在其对抗生素的耐药性方面,因为它们的生长缓慢。在这里,我们描述了目前五种实验室要求苛刻的人类病原体属的微生物诊断现状。对于嗜组织菌属、巴尔通体属、贝纳柯克斯体、东方体属和立克次体属,我们将总结现有的诊断方案、实施新诊断方法的具体限制以及对诊断工具的进一步优化或扩展的需求。我们将探讨包括质谱和下一代核酸测序在内的新技术提供的诊断机会。最后,我们将回顾针对那些病原体生长苛刻、难以检测的疾病快速开发新体外诊断工具的(不)可能性。